Assignee
ARGOS THERAPEUTICS INC
US·18 granted patents·8 pending applications·99 citations·filing 1996–2017
Top patents by PatentIndex Score
26 records- 0196US8030080B2Systems and methods for processing samples in a closed container, and related devicesARGOS THERAPEUTICS INC·Filed 2007·Granted Oct 4, 2011·68 cites·17 claims
- 0281US9527074B2Processing containersARGOS THERAPEUTICS INC·Filed 2016·Granted Dec 27, 2016·1 cites·18 claims
- 0381US7785583B2In situ maturation of dendritic cellsARGOS THERAPEUTICS INC·Filed 2003·Granted Aug 31, 2010·11 cites·11 claims
- 0481US7198948B2Methods and compositions for obtaining mature dendritic cellsARGOS THERAPEUTICS INC·Filed 2002·Granted Apr 3, 2007·10 cites·9 claims
- 0576US9040303B2Apparatus for measuring volume of a fluidARGOS THERAPEUTICS INC·Filed 2013·Granted May 26, 2015·1 cites·21 claims
- 0673US9523077B2Mature dendritic cell compositions and methods for culturing sameARGOS THERAPEUTICS INC·Filed 2013·Granted Dec 20, 2016·2 cites·21 claims
- 0769US7923247B2Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogensARGOS THERAPEUTICS INC·Filed 2008·Granted Apr 12, 2011·0 cites·11 claims
- 0865US9638707B2Methods of processing samplesARGOS THERAPEUTICS INC·Filed 2016·Granted May 2, 2017·0 cites·18 claims
- 0963US9409178B2Processing containersARGOS THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·0 cites·16 claims
- 1062US7893200B2Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseasesARGOS THERAPEUTICS INC·Filed 2003·Granted Feb 22, 2011·3 cites·13 claims
- 1159US9556455B2Mature dendritic cell compositions and methods for culturing sameARGOS THERAPEUTICS INC·Filed 2014·Granted Jan 31, 2017·0 cites·19 claims
- 1259US2016324926A1Use of CD83 in Combination TherapiesARGOS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1359US2016008440A1Use of CD83 in Combination TherapiesARGOS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1457US9732140B2Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseasesARGOS THERAPEUTICS INC·Filed 2014·Granted Aug 15, 2017·0 cites·10 claims
- 1556US10184108B2Mature dendritic cell compositions and methods for culturing sameARGOS THERAPEUTICS INC·Filed 2016·Granted Jan 22, 2019·0 cites·22 claims
- 1656US2015132844A1Dendritic Cell Compositions and MethodsARGOS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1755US2007248578A1Mrna Transfected Antigen Presenting CellsARGOS THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1855US2016102291A1Dendritic Cell Compositions and MethodsARGOS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1954US8361463B2Humanized antibodies against human interferon-alphaARGOS THERAPEUTICS INC·Filed 2012·Granted Jan 29, 2013·0 cites·10 claims
- 2053USRE46152EDendritic cell compositions and methodsARGOS THERAPEUTICS INC·Filed 2006·Granted Sep 20, 2016·0 cites·21 claims
- 2143US10022731B2Centrifuge vessels with a center mound and an internal elongate tube suitable for live cell processing and associated systems and methodsARGOS THERAPEUTICS INC·Filed 2013·Granted Jul 17, 2018·0 cites·21 claims
- 2242US9879053B2Strain-independent amplification of pathogens and vaccines theretoARGOS THERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·0 cites·11 claims
- 2339US2009226404A1Methods for Generating Antigen-Specific Effector T CellsARGOS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2436US7659119B2Method and compositions for obtaining mature dendritic cellsARGOS THERAPEUTICS INC·Filed 1996·Granted Feb 9, 2010·3 cites·10 claims
- 2532US2019315878A1Bispecific antibodies that modulate tlr-4 signaling and uses thereofARGOS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2629US2017065690A1Tscm CELLS AND METHODS FOR USEARGOS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →